158 related articles for article (PubMed ID: 31441324)
1. The Impact of Externally Worn Diabetes Technology on Sexual Behavior and Activity, Body Image, and Anxiety in Type 1 Diabetes.
Robertson C; Lin A; Smith G; Yeung A; Strauss P; Nicholas J; Davis E; Jones T; Gibson L; Richters J; Bock M
J Diabetes Sci Technol; 2020 Mar; 14(2):303-308. PubMed ID: 31441324
[TBL] [Abstract][Full Text] [Related]
2. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
3. Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes.
Vesco AT; Jedraszko AM; Garza KP; Weissberg-Benchell J
J Diabetes Sci Technol; 2018 Jul; 12(4):792-799. PubMed ID: 29595061
[TBL] [Abstract][Full Text] [Related]
4. Perceptions in Type 1 Diabetes Mellitus with or Without the Use of Insulin Pump: An Online Study.
Benioudakis ES
Curr Diabetes Rev; 2020; 16(8):874-880. PubMed ID: 31057119
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
6. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
[TBL] [Abstract][Full Text] [Related]
7. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
8. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial Aspects of Diabetes Technology: Adult Perspective.
Polonsky WH
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):143-155. PubMed ID: 31980114
[TBL] [Abstract][Full Text] [Related]
10. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
[TBL] [Abstract][Full Text] [Related]
11. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
[TBL] [Abstract][Full Text] [Related]
12. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
Grant P; Dworakowska D; DeZoysa N; Barnes D
Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
[No Abstract] [Full Text] [Related]
14. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
[TBL] [Abstract][Full Text] [Related]
15. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Pettus J; Edelman SV
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
[TBL] [Abstract][Full Text] [Related]
16. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
Telo GH; Volkening LK; Butler DA; Laffel LM
Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
[TBL] [Abstract][Full Text] [Related]
17. Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy.
Westen SC; Warnick JL; Albanese-O'Neill A; Schatz DA; Haller MJ; Entessari M; Janicke DM
J Pediatr Psychol; 2019 Jan; 44(1):21-31. PubMed ID: 30184209
[TBL] [Abstract][Full Text] [Related]
18. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
19. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
Rodbard D; Jovanovic L; Garg SK
Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
[TBL] [Abstract][Full Text] [Related]
20. The Development and Psychometric Validation of the Diabetes Impact and Device Satisfaction Scale for Individuals with Type 1 Diabetes.
Manning ML; Singh H; Stoner K; Habif S
J Diabetes Sci Technol; 2020 Mar; 14(2):309-317. PubMed ID: 32028790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
